In the last trading session, 0.22 million shares of the Catheter Precision Inc (AMEX:VTAK) were traded, and its beta was -0.35. Most recently the company’s share price was $0.46, and it changed around -$0.01 or -1.29% from the last close, which brings the market valuation of the company to $3.67M. VTAK currently trades at a discount to its 52-week high of $8.40, offering almost -1726.09% off that amount. The share price’s 52-week low was $0.31, which indicates that the current value has risen by an impressive 32.61% since then. We note from Catheter Precision Inc’s average daily trading volume that its 10-day average is 1.18 million shares, with the 3-month average coming to 3.77 million.
Catheter Precision Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended VTAK as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Catheter Precision Inc (AMEX:VTAK) trade information
Instantly VTAK has showed a red trend with a performance of -1.29% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.5600 on recent trading dayincreased the stock’s daily price by 17.86%. The company’s shares are currently up 1.77% year-to-date, but still down -13.90% over the last five days. On the other hand, Catheter Precision Inc (AMEX:VTAK) is 29.92% up in the 30-day period. We can see from the shorts that 0.18 million shares have been sold at a short interest cover period of 0.02 day(s).
Catheter Precision Inc (VTAK) estimates and forecasts
Catheter Precision Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -83.61 percent over the past six months and at a 92.64% annual growth rate that is well above the industry average of 15.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 66.41%.
VTAK Dividends
Catheter Precision Inc’s next quarterly earnings report is expected to be released in February.
Catheter Precision Inc (AMEX:VTAK)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 13.53% of Catheter Precision Inc shares, and 4.66% of them are in the hands of institutional investors. The stock currently has a share float of 5.39%.
